REC Statistics
Total Valuation
Recordati Industria Chimica e Farmaceutica has a market cap or net worth of EUR 10.66 billion. The enterprise value is 12.15 billion.
Market Cap | 10.66B |
Enterprise Value | 12.15B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | May 20, 2024 |
Share Statistics
Recordati Industria Chimica e Farmaceutica has 204.87 million shares outstanding.
Shares Outstanding | 204.87M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 25.71% |
Float | 98.17M |
Valuation Ratios
The trailing PE ratio is 28.12 and the forward PE ratio is 22.54. Recordati Industria Chimica e Farmaceutica's PEG ratio is 2.68.
PE Ratio | 28.12 |
Forward PE | 22.54 |
PS Ratio | 4.82 |
PB Ratio | 5.95 |
P/FCF Ratio | 23.70 |
PEG Ratio | 2.68 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.11, with an EV/FCF ratio of 26.99.
EV / Earnings | 31.38 |
EV / Sales | 5.46 |
EV / EBITDA | 15.11 |
EV / EBIT | 18.55 |
EV / FCF | 26.99 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 93.23.
Current Ratio | 1.40 |
Quick Ratio | 0.89 |
Debt / Equity | 93.23 |
Debt / EBITDA | 2.09 |
Debt / FCF | 3.74 |
Interest Coverage | 7.78 |
Financial Efficiency
Return on equity (ROE) is 22.67% and return on invested capital (ROIC) is 11.74%.
Return on Equity (ROE) | 22.67% |
Return on Assets (ROA) | 9.73% |
Return on Capital (ROIC) | 11.74% |
Revenue Per Employee | 499,153 |
Profits Per Employee | 86,872 |
Employee Count | 4,455 |
Asset Turnover | 0.53 |
Inventory Turnover | 1.62 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.67% in the last 52 weeks. The beta is 0.40, so Recordati Industria Chimica e Farmaceutica's price volatility has been lower than the market average.
Beta (5Y) | 0.40 |
52-Week Price Change | +13.67% |
50-Day Moving Average | 50.54 |
200-Day Moving Average | 49.79 |
Relative Strength Index (RSI) | 55.34 |
Average Volume (20 Days) | 187,314 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Recordati Industria Chimica e Farmaceutica had revenue of EUR 2.22 billion and earned 387.01 million in profits. Earnings per share was 1.85.
Revenue | 2.22B |
Gross Profit | 1.55B |
Operating Income | 654.71M |
Pretax Income | 493.91M |
Net Income | 387.01M |
EBITDA | 791.51M |
EBIT | 654.71M |
Earnings Per Share (EPS) | 1.85 |
Balance Sheet
The company has 200.58 million in cash and 1.68 billion in debt, giving a net cash position of -1.48 billion or -7.23 per share.
Cash & Cash Equivalents | 200.58M |
Total Debt | 1.68B |
Net Cash | -1.48B |
Net Cash Per Share | -7.23 |
Equity (Book Value) | 1.80B |
Book Value Per Share | 8.74 |
Working Capital | 357.78M |
Cash Flow
In the last 12 months, operating cash flow was 481.03 million and capital expenditures -31.04 million, giving a free cash flow of 450.00 million.
Operating Cash Flow | 481.03M |
Capital Expenditures | -31.04M |
Free Cash Flow | 450.00M |
FCF Per Share | 2.20 |
Margins
Gross margin is 69.75%, with operating and profit margins of 29.44% and 17.40%.
Gross Margin | 69.75% |
Operating Margin | 29.44% |
Pretax Margin | 22.21% |
Profit Margin | 17.40% |
EBITDA Margin | 35.59% |
EBIT Margin | 29.44% |
FCF Margin | 20.24% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 2.27%.
Dividend Per Share | 1.20 |
Dividend Yield | 2.27% |
Dividend Growth (YoY) | 4.35% |
Years of Dividend Growth | 11 |
Payout Ratio | 63.99% |
Buyback Yield | n/a |
Shareholder Yield | 2.27% |
Earnings Yield | 3.56% |
FCF Yield | 4.22% |
Stock Splits
The last stock split was on April 18, 2005. It was a forward split with a ratio of 4.
Last Split Date | Apr 18, 2005 |
Split Type | Forward |
Split Ratio | 4 |